Devices, systems and methods for treating medical devices having passageways with ozone gas

Information

  • Patent Grant
  • 12083239
  • Patent Number
    12,083,239
  • Date Filed
    Wednesday, April 7, 2021
    3 years ago
  • Date Issued
    Tuesday, September 10, 2024
    5 months ago
Abstract
The present disclosure is generally related to devices, methods and systems for cleaning, disinfecting and/or sterilizing a medical device, medical hoses and tubes and accessories thereof with ozone gas, in particular the disclosure relates to devices, methods and systems with multiple receptacles for providing closed-loop fluid pathways to distribute ozone gas to inner passageways and the outer compartments of medical devices. The devices in accordance with an embodiment of the disclosure have two or more receptacles for distributing ozone gas, a gas-tight compartment, an ozone operating system, and one or more connector units configured to fluidly migrate ozone in closed-loop treatment systems.
Description
TECHNICAL FIELD

The present disclosure generally relates to ozone gas treatment of medical devices and more particularly, is related to devices, systems and methods using agents or gas, such as ozone gas, for cleaning, disinfecting and sterilizing medical devices in a ozone device with multiple cleaning, disinfecting and sterilizing properties, with one or more receptacles, and receiving ports and chambers for ease of cleaning, disinfecting and sterilizing medical devices, medical instruments and medical passageways, such as hoses and/or tubes.


BACKGROUND OF THE DISCLOSURE

Medical devices, medical instruments and medical accessories (collectively “medical devices”) require varying degrees of cleaning, disinfection and/or sterilization to prevent bacteria and mold build-up and for safe use and reuse of devices on the same patient and between patients. There are many types of medical devices that have multiple pieces and accessories that require cleaning, disinfection and/or sterilization including, without limitation, hoses, tubes, facemasks, probes, compartments, reservoirs, irrigation systems, pumps and other accessories. Current devices, systems and methods for preparing medical devices for use and/or reuse have proved to be tiring and difficult for users, hospitals and other medical device provider services. Devices often require daily and weekly maintenance steps to prevent bacteria and mold buildup, requiring each part of the device to be cleaned individually, which is difficult and time consuming for users on a daily or weekly basis. Other cleaning methods include soaking the component parts of a medical device in solvents or mixtures for instance of vinegar and water to disinfect the component parts. Because of the inherent nature for many medical devices to collect bacteria and mold, a number of other products are available for consumers to make medical devices safer to use, including but not limited to sprays, UV light devices, cleaning wipes and cleaning brushes.


Ozone gas is powerful and effective for removal of odors, impurities and dangerous pathogens, working by exchanging electron charge with particles that ozone comes into contact with to form oxygen, O2, from the unstable ozone O3. This process is particularly useful for purifying air and water and for killing bacteria and microorganisms that the ozone comes into contact with. Ozonators can be used to create ozone from oxygen molecules, often by applying ultraviolet light to the oxygen. Ozone gas is made of oxygen molecules that have been ionized by radiation to form groups of three oxygen atoms, O3, and may be created, for instance in a device, using an ozonator, air, and the application of ultraviolet light to convert oxygen into ozone gas. However, while ozone gas is a powerful cleaning, disinfecting and sterilizing gas, ozone gas must be contained and controlled as it is not safe for users to breath ozone gas until it has safely converted back to oxygen. The amount of time that is needed for ozone to convert safely from ozone to oxygen varies significantly based on the amount of ozone used in a treatment cycle, in some embodiments ranging from 1 minute to 24 hours.


It is a long felt need in the art to provide a device, systems and methods that can treat medical devices and medical device passageways with one device using ozone gas, requiring minimum disassembly and yet part specific treatment, all in one or more connected and closed-loop systems for safe use treatment with ozone gas and ease of use by a user. It is further a need to provide connector units to connect a variety of medical devices and medical device passageways for treatment with ozone gas.


Other systems, methods, apparatus features, and advantages of the present disclosure will be or become apparent to one with skill in the art upon examination of the following drawings and detailed description. It is intended that all such additional systems, methods, apparatus features, and advantages be included within this description, be within the scope of the present disclosure, and be protected by the accompanying claims.





BRIEF DESCRIPTION OF THE DRAWINGS

Many aspects of the disclosure can be better understood with reference to the following drawings. The components in the drawings are not necessarily to scale, emphasis instead being placed upon clearly illustrating the principles of the present disclosure. Moreover, in the drawings, like reference numerals designate corresponding parts throughout the several views.



FIG. 1 is a perspective view of an ozone treatment device, in accordance with an embodiment of the present disclosure.



FIG. 1A is a perspective view of an ozone treatment device with a connector unit, in accordance with an embodiment of the present disclosure.



FIG. 2 is a schematic illustration of an ozone process in accordance with an embodiment of the present disclosure.



FIG. 2A is a schematic illustration of an ozone process in accordance with an embodiment of the present disclosure.



FIG. 3 is a perspective view of an ozone treatment device coupled to a hose and a medical device, in accordance with an embodiment of the present disclosure.



FIG. 4 is a perspective view of an ozone treatment device with an ozone distribution line for recirculating the ozone into the device, in accordance with an embodiment of the present disclosure.





SUMMARY OF THE DISCLOSURE

The present disclosure relates to a device, system and method for cleaning, disinfecting and sterilizing medical devices, the system comprising, a device with an ozone operating system; a distribution line fluidly connected to the ozone operating system for receiving and distributing ozone gas; a first receptacle on the device, wherein the distribution line is fluidly coupled to the first receptacle for releasing ozone gas; a connector unit, wherein the connector unit is configured to be fluidly connected at a proximal end to the first receptacle on the device and fluidly connected at a distal end to a proximal end of a hose in one embodiment, in another embodiment to be fluidly connected to a second receptacle on the device, and in another embodiment to be fluidly connected to the proximal end of a medical device; and an exhaust port configured to be fluidly coupled to the distal end of the hose, such that ozone gas passes through the fluid passageway and is exhausted.


DETAILED DESCRIPTION


FIG. 1 is a perspective view of an ozone treatment device 100 for treating a medical device tube or hose 115, and medical devices and medical device accessories with ozone. The medical devices may include any medical devices with passageways including, without limitation, tubes and hoses. As used herein, treating with ozone refers to the use of ozone to clean, disinfect and/or sterilize In accordance with this embodiment, an ozone operating system is embedded at the bottom of the device 100 behind a compartment door for ease of access by a user. The ozone operating system in this embodiment including an air pump, such as an aquarium pump, for pumping air and an ozone generator for receiving the air and creating ozone gas. In this embodiment an ozone distribution line 140 is coupled to the ozone operating system wherein the distribution line 140 releases ozone into a first ozone delivering receptacle 105, as shown in FIG. 1. In accordance with this embodiment, the first receptacle 105 is configured to fluidly couple to a proximal end of a medical device hose 115, such as a continuous positive airway pressure device hose. A second ozone receiving receptacle 130 on the device 100 is designed to engage the distal end of the medical device hose 115, such that when a top lid 132 is in a closed position, tabs 131 engage the second receptacle and form a secure seal surrounding the hose 115. In accordance with this embodiment, the second receptacle is fluidly coupled to a gas-tight compartment 135 with an exhaust port 125 embedded therein. The gas-tight compartment 135 can be used to clean, disinfect, and/or sterilize medical devices and accessories made of materials that do not degrade in the presence of ozone, such as CPAP facemasks, as an example, thereby closing a closed loop ozone process. As such the ozone gas traverses from the ozone operating system, to a distribution line, to a first receptacle, through a hose, through a second receptacle, into a gas-tight sanitization chamber, and to an exhaust port. The exhaust port 125 in accordance with this embodiment is coupled to the gas-tight compartment 135 and exhausts ozone from the fluid passageway described in the present embodiment for reuse and/or release. In accordance with this embodiment, an oxidizing catalyst is coupled to the exhaust port 125 for collecting and breaking down ozone gas into oxygen, for safe release. In accordance with this embodiment, ozone generated in the device 100 is released from the ozone operating system into the first receptacle 105 and ozone gas traverses from the device 100 into the hose 115 and is released through the exhaust port 125.


In accordance with the embodiment shown in FIG. 1, the device further includes a third receptacle, 130a, wherein both the second receptacle 130 and the third receptacle 130a have a removable seal 107. In accordance with this embodiment, the removable seal 107 on the second receptacle 130 and third receptacle 130a allows the medical device hose 115 to be fluidly connected into the second receptacle 130 or third receptacle 130a while maintaining a closed-loop system and preventing release of ozone gas from the closed-loop system prior to conversion of the ozone gas back to oxygen. In accordance with this embodiment and the closed-loop system described, the ozone gas is released into a gas-tight compartment 135 to treat medical devices and accessories placed in the gas-tight compartment 135 in the device 100. In accordance with this embodiment, medical devices and accessories can be placed in the gas-tight compartment and cleaned, disinfected and/or sterilized, while hoses and tubes are cleaned, disinfected and/or sterilized with the ozone gas from the ozone operating system, through the first receptacle and into the hose and exhaust port, in a closed-loop system as described. In accordance with this embodiment, the transfer of ozone gas from the ozone operating system to the second and/or third receptacle 130 and 130a, can be accomplished with one or more hoses, distribution lines or connectors.


In accordance with the embodiment shown in FIG. 1, the ozone treatment device 100 also includes a user interface coupled to the ozone operating system 160, a timer coupled to the ozone operating system, a sensor 145 for sensing remaining ozone gas in the hose 115, gas-tight compartments 135 and/or anywhere in the closed loop system, and a safety switch to prevent start of an ozone process or use of a medical devices during an ozone process and an oxidizing catalyst coupled to the exhaust port 125 to collect and break down ozone.



FIG. 1A is a perspective view of an ozone treatment device 100 for cleaning, disinfecting and sterilizing a medical device tube or hose 115, and medical devices and medical device accessories. In accordance with this embodiment, an ozone operating system is embedded in the device 100, the ozone operating system in this embodiment including an air pump, such as an aquarium pump, for pumping air and an ozone generator for receiving the air and creating ozone gas. In this embodiment an ozone distribution line 140 is coupled to the ozone operating system wherein the distribution line 140 releases ozone into a first receptacle 105, as shown in FIG. 1A. In accordance with this embodiment, the first receptacle 105 is configured to be fluidly coupled to a proximal end of a connector unit 110. The connector unit is sized to be fluidly coupled at the distal end of the connector unit to the proximal end to the hose 115. In accordance with this embodiment, the second receptacle 130 on the device 100 is designed to engage the distal end of the hose 115, such that when a top lid 132 is in a closed position, tabs 131, 131a engage the second receptacle and form a secure seal surrounding the hose 115. In accordance with this embodiment the second receptacle 130 is fluidly coupled to an exhaust port 125, in this example, through a gas-tight compartment 135 with the exhaust port 125 embedded in the device 100. The gas-tight compartment 135 can be used to clean, disinfect, and/or sterilize medical devices and accessories made of materials that do not degrade in the presence of ozone, such as CPAP facemasks, as an example, thereby closing a closed loop ozone process. As such, the ozone gas traverses from the ozone operating system, to a distribution line 140, to a first receptacle 105, through a hose 115, through a second receptacle in the hose 115, into a gas-tight compartment 135, and to an exhaust port 125. The exhaust port 125 in accordance with this embodiment is coupled to the to the gas-tight compartment 135 exhausts ozone from the fluid passageway described in the present embodiment for reuse and/or release. In accordance with this embodiment, an oxidizing catalyst is coupled to the exhaust port 125 for collecting and breaking down ozone gas into oxygen, for safe release. In accordance with this embodiment, ozone generated in the device 100 is released from the ozone operating system into the first receptacle 105 and ozone gas traverses from the device 100 into the hose 115 and is released through the exhaust port 125.


In accordance with the embodiment shown in FIG. 1A, the connector unit 110 allows the device 100 to be coupled to any device hose, by providing a first receptacle 105 on the device that fluidly couples to the connector unit 110. For example, in one embodiment the connector unit 110 may be sized to couple at the proximal end to the first receptacle 105 and on the distal end to a CPAP hose 115. In another embodiment, the connector unit 110 may be sized to couple at the proximal end to the hose and at the distal end to an endoscope. Similarly adapters and means to change the distal end of the connector unit 110 to fit a variety of sized tubes for any medical device are disclosed herein.



FIGS. 2 and 2A are schematic sketches showing closed-loop ozone processes in accordance with an embodiment of the present disclosure. In accordance with this embodiment, an ozone treatment system 200 with a reverse loop ozone process is described, wherein the device has a first receptacle 205 and a second receptacle 230 that fluidly couple to a medical device hose 215 for providing a closed loop ozone process in accordance with an embodiment of the present disclosure. In accordance with this embodiment, the ozone treatment system 200 has an ozone operating system 202 including an ozone pump 201 coupled to an ozone generator 203, for producing ozone gas, and a distribution line 240 that carries ozone gas to a first receptacle 205. Ozone gas migrates in this embodiment through the coupled hose 215 and exits the hose into the exhaust port 225, before the ozone gas is release or recycled from the closed-loop system described.


Similar to FIG. 2, FIG. 2A shows an ozone operating system 202 fluidly coupled to a first receptacle 205 with a distribution line 240, with ozone gas migrating into the hose 215 and through the second receptacle 230 on the device 100 into a gas-tight chamber for cleaning, disinfecting and/or sterilizing medical instruments and accessories in the gas tight chamber, before the ozone gas is released or recycles from the closed loop system through an exhaust port 225. In this embodiment an oxide filter 270 is further shown for collecting and breaking down ozone gas into oxygen.


In accordance with the methods disclosed in FIGS. 2 and 2A, a method of treating a medical device with ozone gas is disclosed, the method describing an ozone process of producing ozone gas in a device with an ozone operating system, migrating ozone gas through a distribution line through a first receptacle in the device and into a hose of a medical device, and exhausting ozone gas from the hose of the medical device. In accordance with this method, a second receptacle on the device may be used on the device with an exhaust port and/or a gas-tight compartment coupled to an exhaust port and housed in the device, such that the ozone gas is re-circulated into the device before being removed, released or re-circulated from the system, in a closed-loop ozone process.



FIG. 3 shows a perspective view of an ozone device with an ozone operating system, in accordance with an embodiment of the present disclosure. In this embodiment, a distribution line 340 traverses a first receptacle 305 and attaches at a distal end to a connector unit 310. In this embodiment the distribution line traverses into the connector unit 310, which is coupled at a proximal end to a medical device 350 and at the distal end to a medical device hose 315, and ozone is released into the hose and/or into a cavity in the medical device 350. In this embodiment a second receptacle 330 and a third receptacle 330a, with a seal 307 are provided such that the hose 315 can be connected as shown through the second receptacle 330 to release ozone gas into a gas-tight compartment 335 and be exhausted through exhaust port 325. In accordance with this embodiment, a sensor 345 is provided in the gas-tight compartment 335 to sense the amount of ozone gas in the closed loop system described herein. In this embodiment the sensor 345 is coupled to the user interface 360 for providing ozone process information to a user, including but not limited to ozone levels remaining in the gas tight compartment 335, ozone cycle time, and ozone safety signals. In accordance with this embodiment, the device 300 and the methods and systems described may further have a user interface 360 coupled to the ozone operating system, a timer coupled to the ozone operating system, a safety switch 365 to prevent start of an ozone process or use of a medical device during an ozone process, and an oxidizing catalyst such as an magnesium oxide filter coupled to the exhaust port 325 to collect and break down ozone.


As such, in accordance with one embodiment of the present disclosure, a system comprising, a device 300 with an ozone operating system; a distribution line 340 fluidly connected to the ozone operating system for receiving and distributing ozone gas; a first receptacle 305 on the device, wherein the distribution line 340 traverses the first receptacle and connects to a connector unit 310; the connector unit 310, wherein the connector unit 310 is configured to be fluidly connected to a medical device 350 and to a medical device hose 315; a second receptacle 330 that engages the hose 315 when the lid 332 is in a closed position with a free end immersed in a gas-tight compartment 335 in the device 300, is described.



FIG. 4 is a perspective view of a device 400 with an ozone operating system, showing devices, methods and systems for cleaning, disinfecting and sterilizing medical devices and medical device accessories. In accordance with this embodiment, an ozone operating system is embedded in the device 400, the ozone operating system in this embodiment including an air pump, such as an aquarium pump, for pumping air and an ozone generator for receiving the air and creating ozone gas. In this embodiment an ozone distribution line 440 is coupled to the ozone operating system wherein the distribution line 440 traverses a first receptacle 405, as shown in FIG. 4. In accordance with this embodiment, the first receptacle 405 is configured to allow the distribution line 440 to traverse through the first receptacle 405 and engage the second receptacle, which is fluidly coupled to a gas-tight compartment 435 with an exhaust port 425 embedded therein. The gas-tight compartment 435 can be used to clean, disinfect, and/or sterilize medical devices and accessories made of materials that do not degrade in the presence of ozone, such as CPAP facemasks, as an example, thereby closing a closed loop ozone process, whereby ozone gas traverses from the ozone operating system, to a distribution line, through a first receptacle and second receptacle, into a gas-tight chamber, and to an exhaust port. The exhaust port 425 in accordance with this embodiment is coupled to the to the gas-tight compartment 435 and exhausts ozone from the fluid passageway described in the present embodiment for reuse and/or release. In accordance with this embodiment, an oxidizing catalyst is coupled to the exhaust port 425 for collecting and breaking down ozone gas into oxygen, for safe release.


In accordance with yet another embodiment of the present disclosure, a device with an ozone operating system comprising; a first receptacle, wherein the first receptacle is adapted to fluidly transfer ozone gas from the ozone operating system to a hose; and a second receptacle, wherein the second receptacle is adapted to fluidly transfer ozone gas from the hose to an exhaust port, is described. In accordance with this embodiment the device further comprises a gas-tight compartment, wherein the exhaust port is coupled to the gas-tight compartment. The device in the present embodiment further comprises a connector unit, wherein the first end of the connector unit is configured to fluidly couple to the first receptacle and a second end is configured to fluidly couple to a first end of the hose. In accordance with this embodiment second receptacle on the device is configured to engage with a second end of the hose, allowing ozone gas to be released from the hose, through the second receptacle, into the gas-tight compartment. The device in the present embodiment further comprises a user interface coupled to the ozone operating system, a timer coupled to the ozone operating system, a sensor coupled to the ozone operating system for sensing remaining ozone in the medical device, an air pump coupled to the ozone operating system and an oxidizing catalyst coupled to the exhaust port to collect and break down ozone.


In addition to the devices, systems and methods shown in the proceeding examples, the closed-loop systems described include, in some embodiments, steps for delaying the start of an ozone process of a for a fixed period of time from the last ozone process for the safety of the consumers. The step of delaying the start time may range from may range from about 30 seconds to about 24 hours, depending on the device being treated and the level of cleaning, disinfection and/or sterilization required. In addition the step of sensing remaining ozone in a the medical devices being treated further increases the safety of the present treatment systems and methods for users, while also indicating to users that a medical device has been fully treated in accordance with user guidelines and required ozone exposure numbers. As such, the user interface may display a variety of ozone process information to a user, including but not limited to ozone cycle time, device being treated, ozone levels as detected by sensors, level of treatment required based on an assessment of bacterial, mold, dirt or other criteria on a device being treated, light or sound indicators, and consumable product indicators, for the convenience of users.


The present disclosure discloses, devices, systems and methods of using ozone gas in closed-loop systems to clean, disinfect and/or sterilize medical devices, medical device hoses and tubes and accessories. Examples of medical devices that may be cleaned, disinfected and/or sterilized in accordance with the embodiments described in the present disclosure include but are not limited to: surgical instruments, irrigation systems for sterile instruments in sterile tissues, endoscopes and endoscopic biopsy accessories, duodenoscopes, endotracheal tubes, bronchosopes, laryngosopes blades and other respiratory equipment, esophageal manometry probes, diaphragm fitting rings and gastrointestinal endoscopes, infusion pumps, ventilators, and continuous positive airway pressure devices (CPAP), prone to bacterial build-up because of humidified air and contact with a patients mouth. Many of the devices listed above include passageways that are difficult to clean, disinfect and sterilize, such as any of the endoscopes, probes, ventilators and CPAP devices and related hoses.


The present disclosure thus discloses unique cleaning, disinfecting and sterilizing devices with one or more receptacles and connector units for cleaning, disinfecting and/or sterilizing multiple medical devices, medical tubes and accessories. The devices, systems and methods described may include multiple connector units of different sizes and shapes, multiple ozone distribution lines from a device, wherein the devices may be of any size and shape, a timer, a sensor for sensing ozone in the closed-loop systems, a display for displaying cycle parameters and information, medical device cycle levels, cycle times, a controller for controlling release of ozone into the closed-loop systems, a locking mechanism for locking the device, an exhaust port, and a oxygen catalyst coupled to the exhaust port and uniquely designed connector units that connect to multiple medical devices.


It should be emphasized that the above-described embodiments of the present disclosure, particularly, any “preferred” embodiments, are merely possible examples of implementations, merely set forth for a clear understanding of the principles of the disclosure. Many variations and modifications may be made to the above-described embodiments of the disclosure without departing substantially from the spirit and principles of the disclosure. All such modifications and variations are intended to be included herein within the scope of this disclosure and the present disclosure and protected by the following claims.

Claims
  • 1. An ozone treatment system, comprising: a base comprising a first receptacle and a second receptacle;an ozone operating system within the base and fluidly coupled to the first receptacle, the ozone operating system configured to generate ozone gas;a compartment within the base and fluidly coupled to the second receptacle, the compartment configured to contain at least a part of a medical device;wherein:the ozone operating system is configured to cause at least a portion of said ozone gas to flow outside said base at least in part via said first receptacle; andthe second receptacle is configured to receive at least a portion of said ozone gas from outside said base.
  • 2. The ozone treatment system of claim 1, wherein: at least a portion of said first receptacle extends through at least one wall of said base; andat least a portion of said second receptacle extends through at least one wall of said base.
  • 3. The ozone treatment system of claim 2, wherein: said base further comprises a lid that is movable between an open position and a closed position; andin the closed position at least, a portion of said lid defines at least a portion of said compartment.
  • 4. The ozone treatment system of claim 1, wherein the compartment comprises an exhaust port and the system further comprises a filter fluidly coupled to the exhaust port, the filter configured to convert ozone gas to oxygen.
  • 5. The ozone treatment system of claim 1, further comprising an ozone distribution line fluidly coupled to the first receptacle.
  • 6. The ozone treatment system of claim 5, wherein the ozone distribution line is further fluidly coupled to the ozone operating system.
  • 7. The ozone treatment system of claim 1, wherein: said first receptacle is further configured to fluidly couple to a proximal end of a hose, and to convey at least a portion of said ozone gas into said hose;the second receptacle is further configured to fluidly couple to a distal end of said hose, and to receive and convey ozone gas from said hose into said compartment.
  • 8. The ozone treatment system of claim 7, further comprising said hose, wherein said hose is a continuous positive airway pressure (CPAP) hose.
  • 9. The ozone treatment system of claim 8, wherein said first receptacle is fluidly coupled to the proximal end of said CPAP hose, and the second receptacle is fluidly coupled to the distal end of said CPAP hose.
  • 10. The ozone treatment system of claim 7, further comprising an ozone distribution line fluidly coupled to the first receptacle.
  • 11. The ozone treatment system of claim 10, wherein the ozone distribution line is further fluidly coupled to the ozone operating system.
  • 12. The ozone treatment system of claim 7, wherein: said first receptacle is further configured to couple directly to the proximal end of said hose and to convey at least a portion of said ozone gas into said hose and outside said base; andthe second receptacle is further configured to couple directly to the distal end of said hose, and to receive and convey ozone gas from said hose into said compartment.
  • 13. The ozone treatment system of claim 12, further comprising said hose, wherein the hose is a continuous positive airway pressure (CPAP) hose.
  • 14. The ozone treatment system of claim 7, further comprising a connector unit and said hose, wherein the connector unit is configured to provide at least part of a fluid connection between the first receptacle and the proximal end of said hose, and the connector unit is configured to directly convey ozone gas only into said hose.
  • 15. The ozone treatment system of claim 14, wherein said hose is a continuous positive airway pressure (CPAP) hose.
  • 16. The ozone treatment system of claim 15, wherein: the connector unit comprises a proximal end fluidly coupled to the first receptacle and a distal end coupled directly to the proximal end of said CPAP hose; andthe distal end of said CPAP hose is fluidly coupled to the second receptacle.
  • 17. The ozone treatment system of claim 14, further comprising an ozone distribution line fluidly coupled to the first receptacle and the connector unit.
  • 18. The ozone treatment system of claim 17, wherein the ozone distribution line is further fluidly coupled to the ozone operating system.
  • 19. The ozone treatment system of claim 7, wherein: said base further comprises a lid that is movable between an open position and a closed position; andin the closed position, at least a portion of said lid defines at least a portion of said compartment.
  • 20. The ozone treatment system of claim 7, wherein the compartment comprises an exhaust port and the system further comprises a filter fluidly coupled to the exhaust port, the filter configured to convert ozone gas to oxygen.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 17/194,905, filed Mar. 8, 2021, which is a continuation of U.S. patent application Ser. No. 16/780,355, filed Feb. 3, 2020, (now U.S. Pat. No. 10,940,222), which is a continuation of U.S. patent application Ser. No. 16/190,996, filed Nov. 14, 2018 (now U.S. Pat. No. 10,842,898), which is a continuation of U.S. application Ser. No. 15/873,506 (now U.S. Pat. No. 10,232,072), filed Jan. 17, 2018, which is a Continuation of U.S. patent application Ser. No. 15/481,919 (now U.S. Pat. No. 9,895,461), filed Apr. 7, 2017, which is a continuation of U.S. patent application Ser. No. 15/141,216 (now U.S. Pat. No. 9,669,124), filed Apr. 28, 2016, which is a continuation in part of PCT/US2015/029418, filed May 6, 2015, said U.S. patent application Ser. No. 15/141,216 (now U.S. Pat. No. 9,669,124), filed Apr. 28, 2016, is also a continuation in part of U.S. patent application Ser. No. 14/232,773 (now U.S. Pat. No. 9,358,316), filed Jan. 14, 2014, which is a 371 of International Patent Application No. PCT/US2012/046593, filed Jul. 13, 2012, which claims the benefit of U.S. Patent Application Ser. No. 61/508,341, filed Jul. 15, 2011, the contents of all of which incorporated herein by reference.

US Referenced Citations (165)
Number Name Date Kind
4019986 Burris Apr 1977 A
4035657 Carlson Jul 1977 A
4110419 Miller Aug 1978 A
4207291 Byrd Jun 1980 A
4465522 Taldo et al. Aug 1984 A
4517159 Karlson May 1985 A
D295074 Jerge Apr 1988 S
4743275 Flanagan May 1988 A
4787980 Ackermann Nov 1988 A
5029879 Strang Jul 1991 A
5120512 Masuda Jun 1992 A
5207237 Langford May 1993 A
5344622 Faddis et al. Sep 1994 A
5508006 Gabele Apr 1996 A
5520893 Kasting, Jr. et al. May 1996 A
D371203 Deeds Jun 1996 S
D390645 Hanrahan Feb 1998 S
5761069 Webber et al. Jun 1998 A
5920075 Whitehead Jul 1999 A
6024066 Nakayama et al. Feb 2000 A
6134806 Dhaemers Oct 2000 A
6158784 Lavender Dec 2000 A
6276304 Tai Aug 2001 B1
6280633 Conrad Aug 2001 B1
6365601 Fournier Apr 2002 B1
6379617 Spickermann Apr 2002 B1
6379632 Kinoshita Apr 2002 B1
D476423 Picot Jun 2003 S
6576190 Park Jun 2003 B1
6605260 Busted Aug 2003 B1
D487315 Picot Mar 2004 S
6752151 Hill Jun 2004 B2
7022225 Clawson Apr 2006 B1
7491321 Maas et al. Feb 2009 B1
7520910 Tilley Apr 2009 B2
7527603 An May 2009 B2
7608217 Champagne Oct 2009 B2
7676276 Karell Mar 2010 B2
7767168 Namespetra Aug 2010 B2
7794522 Bliss Sep 2010 B2
7845350 Kayyali Dec 2010 B1
8051853 Berthon-Jones Nov 2011 B2
8146946 Emond Apr 2012 B1
8176771 Onishi May 2012 B2
8215465 Iceberg Jul 2012 B2
8431075 Fraundorfer Apr 2013 B2
D692155 Matoba Oct 2013 S
8677842 Devine Mar 2014 B2
8770198 Yee Jul 2014 B2
8815164 Al Azemi Aug 2014 B1
D719673 Leyva Dec 2014 S
D719674 Leyva Dec 2014 S
8915380 Sowerby Dec 2014 B2
9022247 Enigmann May 2015 B2
D733315 Lui Jun 2015 S
D733316 Lui Jun 2015 S
D748280 Lui Jan 2016 S
9358311 Leyva Jun 2016 B2
D761142 Golta Jul 2016 S
9402928 Tremblay Aug 2016 B2
9452274 Addington et al. Sep 2016 B2
D776290 Wan Jan 2017 S
9572944 Van Der Sluis et al. Feb 2017 B2
9610373 Leyva Apr 2017 B2
9616147 Leyva Apr 2017 B2
9669124 Leyva Jun 2017 B2
D802788 Cormier Nov 2017 S
9814795 Dufresne et al. Nov 2017 B2
9895461 Leyva Feb 2018 B2
9907872 Schmidt Mar 2018 B2
D819190 Cormier May 2018 S
9956309 Leyva May 2018 B1
10052397 Leyva Aug 2018 B2
10232072 Leyva Mar 2019 B2
10264913 Leyva Apr 2019 B2
10398797 Leyva Sep 2019 B2
10427961 Leyva Oct 2019 B2
10434204 Leyva Oct 2019 B2
10434205 Leyva Oct 2019 B2
10456492 Leyva Oct 2019 B2
10485888 Schmidt Nov 2019 B2
10842897 Schwartz Nov 2020 B2
10980905 Bohman Apr 2021 B2
11000611 He May 2021 B1
11285289 Wilkins Mar 2022 B2
11484613 Maw et al. Nov 2022 B2
11993522 Leyva et al. May 2024 B2
20020139124 Palermo Oct 2002 A1
20030000966 Shelton Jan 2003 A1
20030063997 Fryer Apr 2003 A1
20030065292 Darouiche Apr 2003 A1
20030065297 Davis Apr 2003 A1
20030071069 Shelton Apr 2003 A1
20040007000 Takeda Jan 2004 A1
20040028583 Hedman Feb 2004 A1
20040202570 Nadkarni Oct 2004 A1
20040251125 Yu Dec 2004 A1
20050017380 Namespetra et al. Jan 2005 A1
20050019237 Riley Jan 2005 A1
20050168907 Sekoguchi Aug 2005 A1
20050186108 Fields Aug 2005 A1
20050191219 Uslenghi et al. Sep 2005 A1
20050220665 Ding Oct 2005 A1
20060034737 Beam et al. Feb 2006 A1
20060130834 Chen Jun 2006 A1
20060272682 Langford Dec 2006 A1
20070031778 Helfenbein Feb 2007 A1
20070065335 Bedard Mar 2007 A1
20070110611 Teran et al. May 2007 A1
20080050290 Yui Feb 2008 A1
20080118411 D'Arinzo May 2008 A1
20090004047 Hunter et al. Jan 2009 A1
20090080809 Pham Mar 2009 A1
20090267242 Nichols Oct 2009 A1
20100047116 Garner Feb 2010 A1
20100059431 Cho Mar 2010 A1
20100111792 Nelson May 2010 A1
20100112677 Onishi May 2010 A1
20100147302 Selvarajan Jun 2010 A1
20110031081 Iceberg Feb 2011 A1
20120164025 Stockley, III et al. Jun 2012 A1
20120189490 Van Den Bossche et al. Jul 2012 A1
20120227745 Arcilla Sep 2012 A1
20130177475 Finch Jul 2013 A1
20130239994 Przyjemski Sep 2013 A1
20140112837 Huang Apr 2014 A1
20140154134 Leyva Jun 2014 A1
20140193294 Kain et al. Jul 2014 A1
20150004061 Kain Jan 2015 A1
20160235875 Schmidt et al. Aug 2016 A1
20160235876 Leyva et al. Aug 2016 A1
20160243268 Leyva Aug 2016 A1
20170157278 Schmidt et al. Jun 2017 A1
20170165443 Leyva Jun 2017 A1
20170202990 Leyva Jul 2017 A1
20170209610 Leyva Jul 2017 A1
20170224857 Leyva Aug 2017 A1
20170225985 Leyva Aug 2017 A1
20170370013 Bahar Dec 2017 A1
20180028770 Parrish Feb 2018 A1
20180161466 Schmidt Jun 2018 A1
20180207307 Schwartz Jul 2018 A1
20180250431 Eide et al. Sep 2018 A1
20180264157 Benedek Sep 2018 A1
20180311391 Leyva Nov 2018 A1
20180311595 Leyva Nov 2018 A1
20190076561 Leyva Mar 2019 A1
20190076562 Schmidt Mar 2019 A1
20190083668 Schmidt Mar 2019 A1
20190151487 Leyva May 2019 A1
20190167828 Leyva Jun 2019 A1
20190336627 Lucio Nov 2019 A1
20190388575 Leyva et al. Dec 2019 A1
20200000950 Bohman Jan 2020 A1
20200024167 Leyva et al. Jan 2020 A1
20200069362 Paesch Mar 2020 A1
20210023250 Golkowski et al. Jan 2021 A1
20210196850 Maw et al. Jul 2021 A1
20210338873 Maw et al. Nov 2021 A1
20220193364 Wilkins et al. Jun 2022 A1
20230007917 Maw et al. Jan 2023 A1
20230062589 Leyva Mar 2023 A1
20230173119 Leyva Jun 2023 A1
20240058493 Schmidt et al. Feb 2024 A1
20240091396 Knight Mar 2024 A1
Foreign Referenced Citations (48)
Number Date Country
1377708 Nov 2002 CN
2659447 Dec 2004 CN
2710637 Jul 2005 CN
1951507 Apr 2007 CN
2905066 May 2007 CN
201156965 Dec 2008 CN
102497916 Jun 2012 CN
103781498 May 2014 CN
103781498 May 2014 CN
204261187 Apr 2015 CN
105031693 Nov 2015 CN
105031693 Nov 2015 CN
2731632 Aug 2017 CN
108671253 Oct 2018 CN
109069675 Dec 2018 CN
213910114 Aug 2021 CN
114796745 Jul 2022 CN
217138746 Aug 2022 CN
2841208 Mar 2015 EP
2731632 Aug 2017 EP
2362426 Jul 2011 ES
2704136 Nov 2018 ES
S62230601 Oct 1987 JP
H0724064 Jan 1995 JP
200288091 Oct 2000 JP
2004148075 May 2004 JP
2005270589 Oct 2005 JP
2009131354 Jun 2009 JP
2012020207 Feb 2012 JP
2014523327 Jan 2013 JP
5423813 Feb 2014 JP
6397764 Sep 2018 JP
20040098412 Nov 2004 KR
101839063 Mar 2018 KR
03068274 Aug 2003 WO
03068274 Aug 2003 WO
2008116165 Sep 2008 WO
2011058472 May 2011 WO
2011086810 Jul 2011 WO
2013012696 Jan 2013 WO
2015171730 Nov 2015 WO
2015171730 Nov 2015 WO
2017189915 Nov 2017 WO
2017189916 Nov 2017 WO
2017189916 Nov 2017 WO
2018200525 Nov 2018 WO
2020191194 Sep 2020 WO
2022034395 Feb 2022 WO
Non-Patent Literature Citations (88)
Entry
Preliminary Report on Patentability mailed Nov. 8, 2018, issued in PCT International Patent Application No. PCT/US2017/029949, 9 pages.
Chaunet et al., “The Sterilization Technology for the 21st Century”, TS03, Inc. Québec, Canada, 2007.
Office Action mailed Oct. 20, 2021 in U.S. Appl. No. 17/025,634. 9 pages.
Goodknight 420G Patient Manual, 2005, Nellcor Puritan Bennett Inc., pp. i-vi; pp. 1-23.
Office Action mailed May 10, 2021, issued in Indian Patent Application No. 201827043772, 8 pages.
SoClean 2 PAP Disinfecting Device User Guide Copyright 2011-2014, Inceptus, Inc.
Ohkawa et al. “High grade disinfection using high-density ozone,” J Adv Oxid Tech, 7, 154-160, (2004).
International Search Report and Written Opinion dated Aug. 16, 2017, issued in PCT Patent Application No. PCT/US17/29950, 11 pages.
U.S. Office Action dated Aug. 3, 2017, issued in U.S. Appl. No. 15/141,152, 14 pages.
International Search Report and Written Opinion dated Aug. 2, 2017, issued in PCT Patent Application No. PCT/US17/29949, 11 pages.
U.S. Office Action dated Jun. 13, 2017, issued in U.S. Appl. No. 15/481,919, 10 pages.
Keep your CPAP machine clean and safe, Oct. 18, 2010—Available at https://www.cpap.co.uk/2010/10/keep-your-cpap-machine-clean-and-safe.
GoodKnight H20 Heated Humidifier User's Manual, 2006 Nellcor Puritan Bennett Inc., pp. i-iv and 1-16.
Hoffrichter Trend II User's Manual (date unknown), Germany, pp. 1-79.
Hudson RCI Product Catalog (2004-2005).
KnightStar(R) 330 User's Manual, 2006, Nellcor Puritan Bennett, 68 pages.
DeVilbiss® DV54 AutoAdjust CPAP Series (DeVilbiss® SleepCube Positive Airway Pressure Device) User Manual (2009). Available at https://www.manualslib.com/manual/1577762/Devilbiss-Intellipap-Dv54.html, pp. 1-183.
Sunset Healthcare Solutions, Inc's Preliminary Patent Disclosures Pursuant to Local Rule 16.6(d)(4) in SoClean, Inc. v. Sunset Healthcare Solutions, Inc, in Civil Action No. 1:20-cv-10351-IT.
Sunset Healthcare Solutions, Inc's Second Amended Counterclaims in SoClean, Inc. v. Sunset Healthcare Solutions, Inc, in Civil Action No. 1:20-cv-10351-IT and Consolidated Case No. 1:21-cv-1013IT.
Memorandum in Support of SoClean's Motion to Dismiss Counts Eight and Nine of Sunset's Second Amended Counterclaims, SoClean, Inc. v. Sunset Healthcare Solutions, Inc, in Civil Action No. 1:20-cv-10351-IT and Consolidated Case No. 1:21-cv-1013IT.
Defendant Sunset's Memorandum in Opposition to SoClean's Motion to Dismiss Counts Eight and Nine of Sunset's Second Amended Counterclaims. C.A. No. 1:20-cv-10351-IT. Filed Jul. 23, 2021, 165 pages.
9055 Series DeVilbiss RPM Bilevel CPAP System Instruction Manual, 66 pages.
Al Ashry, et al. “Humidification during Mechanical Ventilation in the Adult Patient”, vol. 2014, Article ID 715434, Hindawi Publishing Corporation, BioMed Research International. 12 pages.
Murphy, “Ozone—The Latest Advance in Sterilization of Medical Developments”, Canadian Operating Room Nursing Journal, vol. 24, No. 2, Jun. 2006, pp. 28, 30-32, 37 and 38.
Ishizaki, et al., “Inactivation of Bacillus Spores by Gaseous Ozone”, Journal of Applied Bacteriology, 1986, 60, 67-72.
Tornado, New Kind of CPAP Guardian, User Manual, Sunset, 8 pages.
Office Action dated Apr. 28, 2021 in JP 2019-201674, 3 pages.
First Examination Report issued in Indian Patent Application No. 60/MUMNP/2014, mailed Jul. 10, 2019, 6 pages.
Office Action dated Nov. 18, 2020 in CN 201780025983.6.
Office Action dated May 18, 2021 in CN 201780025983.6.
Office Action dated Nov. 1, 2020 in KR 10-2020-7026960.
Office Action mailed Jul. 26, 2021, issued in Chinese Patent Application No. 2017101790472, 4 pages.
Office Action mailed May 29, 2020, issued in Chinese Patent Application No. 2017101795495, 4 pages.
Office Action mailed Jul. 1, 2020, issued in Chinese Patent Application No. 2017101790472.
Office Action mailed Jul. 3, 2020, issued in Chinese Patent Application No. 2017101786388, 8 pages.
Restriction Requirement issued in related U.S. Appl. No. 17/025,634, mailed Aug. 2, 2021 (6 pages).
Office Action dated May 11, 2021 in BR112018-071444-5.
China Office Action from related matter CN201780025983.6 mailed May 9, 2020.
China Office Action from related matter CN201710179459.5 mailed May 29, 2020.
International Search Report and Written Opinion from related matter PCT/US20/23631 mailed Jun. 3, 2020.
China Office Action from related application CN 201710186091 dated Jul. 1, 2020.
China Office Action from related application CN 20171017904.2 dated Jul. 1, 2020.
US Office Action from related matter U.S. Appl. No. 16/191,059 mailed Jun. 11, 2020.
US Final Office Action from related matter U.S. Appl. No. 16/294,097 mailed Jun. 11, 2020.
US Office Action from related matter U.S. Appl. No. 15/880,962 mailed Jun. 11, 2020.
Office Action mailed Jul. 29, 2019, issued in Chinese Patent Application No. 2017101786091, 10 pages.
Office Action mailed Jul. 29, 2019, issued in Chinese Patent Application No. 2017101790472.
Office Action mailed Aug. 6, 2019, issued in Chinese Patent Application No. 2017101795495, 9 pages.
Notice of Allowance mailed Aug. 8, 2019, issued in U.S. Appl. No. 15/141,152, 8 pages.
Examination Report mailed Aug. 13, 2019, issued in Australian Patent Application No. 2018200514, 6 pages.
Notice of Acceptance mailed Aug. 14, 2019, issued in Australian Patent Application No. 2017228723, 4 pages.
Notice of Allowance mailed Oct. 8, 2019, issued in Japanese Application No. 2017-149891, 4 pages.
Examination Report mailed Jun. 7, 2019, issued in Canadian Patent Application No. 3,005,981, 3 pages.
Office Action mailed Jan. 8, 2021, issued in Chinese Patent Application No. 2017101786388, 8 pages.
Notice of Allowance mailed Nov. 15, 2019, issued in Australian Patent Application No. 2018200514, 4 pages.
Extended Search Report mailed Nov. 29, 2019, issued in European Patent Application No. 17790471.1, 9 pages.
Examination Report mailed Jan. 13, 2020, issued in Chilean Patent Application No. 201803063, 17 pages. English language machine translation included.
Office Action mailed Feb. 3, 2020, issued in U.S. Appl. No. 16/190,996, 9 pages.
Office Action mailed Feb. 18, 2020, issued in Canadian Patent Application No. 3,005,981, 3 pages.
Office Action mailed Mar. 19, 2020, issued in Korean Patent Application No. 10-2020-7003298, 4 pages.
Office Action mailed Apr. 7, 2020, issued in U.S. Appl. No. 16/780,492, 13 pages.
Office Action mailed Apr. 13, 2020, issued in U.S. Appl. No. 16/782,892, 15 pages.
Notice of Allowance mailed Apr. 28, 2020, issued in U.S. Appl. No. 16/780,492, 7 pages.
Office Action mailed Apr. 23, 2020, issued in U.S. Appl. No. 16/780,355, 14 pages.
Final Office Action mailed Feb. 5, 2019, issued in U.S. Appl. No. 15/141,152, 14 pages.
Examination Report mailed Feb. 15, 2019, issued in Australian Patent Application No. 2018200514, 5 pages.
Notice of Allowance mailed Apr. 30, 2019, issued in U.S. Appl. No. 15/441,929, 5 pages.
Office Action mailed Mar. 4, 2019, issued in U.S. Appl. No. 16/257,898, 13 pages.
Office Action mailed Mar. 14, 2019, issued in U.S. Appl. No. 16/270,141, 12 pages.
Notice of Allowance mailed Mar. 19, 2019, issued in U.S. Appl. No. 15/499,456, 12 pages.
Extended European Search Report from related Application No. 20773414.6 mailed Nov. 17, 2022. 4 pages.
Office Action mailed Apr. 2, 2019, issued in Japanese Patent Application No. 2017-0149891, 7 pages.
Office Action mailed Oct. 30, 2018, issued in U.S. Appl. No. 15/499,456, 13 pages.
Notice of Allowance mailed Oct. 31, 2018, issued in U.S. Appl. No. 15/873,506, 8 pages.
Office Action amendment mailed Oct. 31, 2018, issued in U.S. Appl. No. 15/499,456, 13 pages.
Office Action mailed Nov. 6, 2018, issued in U.S. Appl. No. 15/499,378, 18 pages.
Office Action from related Chinese Appln. No. 201780025983.6, dated Sep. 11, 2023. English translation.
International Search Report and Written Opinion from corresponding PCT Appln. No. PCT/US2023/032840, dated Nov. 7, 2023. 7 pages.
SoClean Sterisafe PowerPoint Presentation, “Mission Booster Feasability Study Conclusions”, Sep. 14, 2022, 31 slides.
SoClean Humidifier PowerPoint Presentation, “Bettering Lives Through the Power of a Better Clean”, Sep. 16, 2022, 16 slides.
SoClean Purpose, Scope & Executive Summary PowerPoint Presentation, 2022, 52 slides.
Final Office Action mailed Jul. 12, 2023, issued in U.S. Appl. No. 17/013,280, 13 pages.
Office Action from related Chinese Appln. No. 2020800368587, dated Jan. 20, 2023. English translation attached. 10 pages.
Office Action mailed Jan. 23, 2023, issued in U.S. Appl. No. 17/013,280,14 pages.
Office Action mailed Dec. 28, 2023, issued in U.S. Appl. No. 17/239,112, 10 pages.
Office Action mailed Apr. 22, 2022, issued in U.S. Appl. No. 17/464,154, 12 pages.
Office Action from related Chinese Appln. No. 202080036858.7, dated Aug. 29, 2023. English translation.
European Search Report from related Application No. 17790471.1, dated Oct. 18, 2023. 10 pages.
Related Publications (1)
Number Date Country
20210220501 A1 Jul 2021 US
Provisional Applications (1)
Number Date Country
61508341 Jul 2011 US
Continuations (6)
Number Date Country
Parent 17194905 Mar 2021 US
Child 17224590 US
Parent 16780355 Feb 2020 US
Child 17194905 US
Parent 16190996 Nov 2018 US
Child 16780355 US
Parent 15873506 Jan 2018 US
Child 16190996 US
Parent 15481919 Apr 2017 US
Child 15873506 US
Parent 15141216 Apr 2016 US
Child 15481919 US
Continuation in Parts (2)
Number Date Country
Parent PCT/US2015/029418 May 2015 WO
Child 15141216 US
Parent 14232773 US
Child 15141216 US